Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
66.85
+0.15 (0.22%)
Sep 3, 2026, 3:10 PM AST

TADAWUL:4016 Cash Flow Statement

Millions SAR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
108.597.0179.8565.8359.4566.28
Depreciation & Amortization
9.2312.229.87.616.846.7
Other Amortization
11.847.786.044.323.782.87
Loss (Gain) From Sale of Assets
-0.1-0.04-0.12-0.13-0.080.03
Asset Writedown & Restructuring Costs
0.070.07-0.450.06-
Loss (Gain) From Sale of Investments
-0.28----2.76
Provision & Write-off of Bad Debts
4.031.473.54-1.510.13-
Other Operating Activities
5.644.3210.575.777.91-0.88
Change in Accounts Receivable
-56.3-40.82-57.66-5.1712.66-54.5
Change in Inventory
-13.31-7.22-11.712.45-27.388.19
Change in Accounts Payable
5.0116.67-1.03-9.915.226.53
Change in Other Net Operating Assets
-5.03-2.93-6.2212.95-0.032.74
Operating Cash Flow
69.388.5433.0892.6668.5740.72
Operating Cash Flow Growth
56.41%167.68%-64.30%35.14%68.40%-8.33%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-20.59-14.79-11.17-20.83-9.58-15.43
Sale of Property, Plant & Equipment
0.040.040.140.140.410.04
Sale (Purchase) of Intangibles
-27.62-19.62-9.78-10.14-11.03-9.25
Investment in Securities
-28.28-0.77---0.17
Investing Cash Flow
-76.45-34.38-20.04-30.83-20.2-24.8

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-42.3987.19174.13121.94-
Long-Term Debt Issued
-26.14---83.52
Total Debt Issued
118.5968.5387.19174.13121.9483.52
Short-Term Debt Repaid
--65.09-77.38-192.99-119.25-
Long-Term Debt Repaid
--3.48-6.34-6.34-4.75-59.13
Total Debt Repaid
-68.54-68.56-83.72-199.33-124-59.13
Net Debt Issued (Repaid)
50.06-0.033.48-25.2-2.0624.38
Common Dividends Paid
-48.4-46.98-15-36-36.35-37.2
Other Financing Activities
-3.26-3.226.02-9.31-5.2-
Financing Cash Flow
-1.6-50.23-5.5-70.51-43.61-12.82

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
---0.02--0.01
Net Cash Flow
-8.753.937.52-8.684.763.11

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
48.7173.7421.9171.8258.9925.28
Free Cash Flow Growth
84.95%236.62%-69.50%21.76%133.30%121.46%
Free Cash Flow Margin
9.51%16.01%5.56%21.22%19.49%8.80%
Free Cash Flow Per Share
1.392.110.632.051.690.72
Levered Free Cash Flow
-2323.27-5.4729.2622.98-6.24
Unlevered Free Cash Flow
-19.5925.3-3.1732.8625.94-5.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.223.221.464.333.93-
Change in Working Capital
-69.63-34.29-76.610.31-9.53-37.05